• Rapid reduction of severe asymptomatic hypertension with orally administered antihypertensive medication has become a common emergency department practice. To determine if antihypertensive loading prior to initiation of maintenance therapy improved or hastened blood pressure control, 64 asymptomatic patients with severe hypertension were randomized to treatment with (1) hourly doses of clonidine hydrochloride followed by maintenance therapy (group 1); (2) an initial dose of clonidine followed by hourly placebo and subsequent maintenance therapy (group 2); or (3) maintenance therapy without prior loading (group 3). There was no difference between groups 1 and 2 in the time required to achieve acceptable blood pressure control during loading therapy, nor was there a difference at 24 hours in pressure reduction between groups 1,2, or 3. Further follow-up in 44 of these patients at 1 week demonstrated adequate control of systemic blood pressure in all groups, but no difference between groups. In view of the small but reported risk of antihypertensive loading and the burden and expense of prolonged emergency department therapy, these results suggest that the common practice of acute oral antihypertensive loading to treat severe, asymptomatic hypertension should be reconsidered.
(Arch Intern Med. 1989;149:2186-2189)
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 37
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.